Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results
Rhea-AI Summary
Zimmer Biomet (NYSE: ZBH) announced its fourth-quarter 2025 earnings conference call will be webcast on Tuesday, February 10, 2026 at 8:30 a.m. ET. A news release with quarterly results will be published the same day at 6:30 a.m. ET. A live audio webcast and replay will be available via the company's investor relations site: https://investor.zimmerbiomet.com. U.S. and Canada dial-in is (800) 330-6710; international callers may use +1 (213) 279-1505. Use conference ID 7090861 to join the call.
Positive
- None.
Negative
- None.
News Market Reaction – ZBH
On the day this news was published, ZBH declined 0.55%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
ZBH was up 1.02% with elevated volume, while key device peers like SNN, PHG, STE and PODD also showed gains between 0.84% and 2.13%, and DXCM slipped 0.5%, suggesting mixed but generally constructive sector tone rather than a synchronized move driven by this scheduling update.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 22 | Conference presentation | Neutral | +0.8% | Management participation at J.P. Morgan Healthcare Conference webcast. |
| Dec 17 | Dividend declaration | Positive | +0.7% | Announced $0.24 per share quarterly cash dividend for Q4 2025. |
| Dec 16 | Digital health deal | Positive | -1.6% | Exclusive collaboration with OneStep to enhance mymobility platform. |
| Nov 14 | FDA clearance | Positive | -0.7% | U.S. FDA 510(k) clearance for enhanced ROSA Knee with OptimiZe. |
| Nov 07 | Conference presentation | Neutral | -0.0% | Jefferies Global Healthcare Conference appearance and webcast details. |
Recent news flow shows modest single-day moves, with positive product and collaboration updates sometimes met with mild downside, while dividends and conference-related items tilted to small gains.
Over the last few months, Zimmer Biomet’s news has centered on conferences, product enhancements, collaborations and capital returns. In November 2025, the company received U.S. FDA 510(k) clearance for an enhanced ROSA Knee system and announced targeted release later in 2025 with expected U.S. availability in Q1 2026. A collaboration with OneStep on Dec 16, 2025 expanded digital mobility analytics. The company also maintained shareholder returns via a $0.24 quarterly dividend declared on Dec 17, 2025. Multiple conference presentations highlighted ongoing investor outreach, providing context for today’s Q4 2025 earnings call scheduling.
Market Pulse Summary
This announcement schedules Zimmer Biomet’s Q4 2025 earnings release for 6:30 a.m. ET and its conference call for 8:30 a.m. ET on February 10, 2026. Historically, similar webcast notices produced average moves of 1.72%, suggesting they function mainly as timing signals. Investors may focus on prior developments, such as FDA 510(k) clearance for enhanced ROSA Knee and the maintained $0.24 dividend, while awaiting concrete revenue, margin, and guidance figures from the upcoming report.
AI-generated analysis. Not financial advice.
WARSAW, Ind., Jan. 15, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its fourth quarter earnings conference call will be webcast on Tuesday, February 10, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.
Individuals in the
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
Contacts:
Media | Investors |
Troy Kirkpatrick | David DeMartino |
614-284-1926 | 646-531-6115 |
Kirsten Fallon | Zach Weiner |
781-779-5561 | 908-591-6955 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-webcast-and-conference-call-of-fourth-quarter-2025-financial-results-302661459.html
SOURCE Zimmer Biomet Holdings, Inc.
FAQ
When will Zimmer Biomet (ZBH) report fourth-quarter 2025 results?
What time is the Zimmer Biomet (ZBH) Q4 2025 earnings webcast?
How can I access the Zimmer Biomet (ZBH) live audio webcast and replay?
What dial-in number and conference ID are required for the Zimmer Biomet (ZBH) earnings call?
Will the Zimmer Biomet (ZBH) Q4 2025 call be available for replay after the live event?
Where should investors go for the official Zimmer Biomet (ZBH) Q4 2025 earnings materials?
